VENLO, the Netherlands, May 07, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its Supervisory Board will propose the initiation of an annual ...

"I am honored to take on this role and support the next phase of QIAGEN’s growth. I deeply believe in our mission and in QIAGEN’s ability to deliver critical molecular insights that advance ...

I'm Lisa, your PGI call operator. Welcome, and thank you for joining Qiagen's Q1 2025 Earnings Conference Call Webcast. At this time all participants are in a listen-only mode. Please be advised ...

Dr. Elaine Mardis will also not stand for re-election after serving since 2014 All other current Supervisory Board members will stand for re-election to one-year terms QIAGEN N.V. (NYSE ...

diluted EPS outlook reaffirmed for about $2.35 CER QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today confirmed strong Q1 2025 results in line with the preliminary announcement and ...

Qiagen (QGEN) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.47 per share a year ago. These figures ...

PL VENLO, Netherlands (AP) — PL VENLO, Netherlands (AP) — Qiagen NV (QGEN) on Wednesday reported first-quarter profit of $90.8 million. On a per-share basis, the Pl Venlo, Netherlands-based ...

Dr. Elaine Mardis will also not stand for re-election after serving since 2014 All other current Supervisory Board members will stand for re-election to one-year terms VENLO, the Netherlands, May 07, ...

VENLO, the Netherlands - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a global provider of Sample to Insight solutions with a market capitalization of $9.2 billion and strong financial ...